Technology
Health
Pharmaceutical

Intersect ENT

$20.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.34%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Intersect ENT and other stocks, options, ETFs, and crypto commission-free!

About XENT

Intersect ENT, Inc. Common Stock, also called Intersect ENT, is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Read More The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Employees
393
Headquarters
Menlo Park, California
Founded
2003
Market Cap
639.13M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
310.27K
High Today
$20.60
Low Today
$20.30
Open Price
$20.55
Volume
277.08K
52 Week High
$35.87
52 Week Low
$20.14

Collections

Technology
Health
Pharmaceutical
2014 IPO
US
North America

XENT News

BenzingaJul 10

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Intersect ENT, Inc.

0

XENT Earnings

-$0.35
-$0.27
-$0.19
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 1, After Hours

More XENT News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.